Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.37 |
| ▸ | DNM2 | P50570 | 8/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31648525 | 0.79 | TLR8 (0.49) | TLR8HCAR3DNM2SOAT1 | |
| SCHEMBL31647858 | 0.78 | ABL1 (0.34) | TLR8ABL1HCAR3DNM2SOAT1 | |
| SCHEMBL16019053 | 0.77 | TLR8 (0.46) | TLR8HCAR3DNM2 | |
| SCHEMBL31647879 | 0.76 | FGFR1 (0.52) | TLR8FGFR1 | |
| SCHEMBL31648041 | 0.75 | TLR8 (0.41) | TLR8TLR7SOAT1 | |
| SCHEMBL31648433 | 0.74 | FGFR1 (0.45) | HCAR3FGFR1 | |
| SCHEMBL16019055 | 0.72 | TLR8 (0.51) | TLR8HCAR3 | |
| SCHEMBL547309 | 0.69 | TLR8 (0.48) | TLR8HCAR3DNM2TLR7SOAT1 | |
| SCHEMBL16019054 | 0.68 | HRH3 (0.50) | TLR8 | |
| SCHEMBL11498443 | 0.67 | TLR8 (0.45) | TLR8ABL1HCAR3DNM2SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133660-A1 | NOVEL COMPOUNDS FOR HOST DIRECTED ANTIVIRAL STRATEGY | SORBONNE UNIVERSITE (FR) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025132449-A1 | NOVEL COMPOUNDS FOR HOST DIRECTED ANTIVIRAL STRATEGY | SORBONNE UNIVERSITE (FR) | 2025-06-26 | — | — | WO | disclosed |